“Incidence Rate and Time to Serious Adverse Events Among Rifampicin Resistant Tuberculosis Patients in Georgia Treated With New and Repurposed Anti-Tuberculosis Drugs, 2016-2018 ”. Monaldi Archives for Chest Disease 91, no. 1 (January 14, 2021). Accessed June 12, 2025. https://www.monaldi-archives.org/macd/article/view/1649.